Skip to main content
Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery 2/2019

18.10.2018 | Original Article

“RFEF” and mitral regurgitation jet direction: surrogate markers for likelihood of left ventricle reverse remodeling in patients with moderate chronic ischemic mitral regurgitation

verfasst von: Sumbul Siddiqui, Amber Malhotra, Komal Shah, Pankaj Garg, Pranav Sharma, Vivek Wadhawa, Kartik Patel, Anand Shukla

Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Surgical management of moderate chronic ischemic mitral regurgitation (CIMR) is controversial. We propose a simplified classification of moderate CIMR based on regurgitant fraction (RF), ejection fraction (EF), and jet direction (central/eccentric) to predict left ventricle (LV) remodeling and identify patient subsets which need mitral valve (MV) repair along with coronary artery bypass grafting (CABG).

Methods

In this prospective controlled study (n = 210), patients with moderate CIMR were randomized. Group I (n = 106) underwent off-pump CABG alone while group II (n = 104) underwent CABG + MV repair. The product of regurgitation fraction and ejection fraction (“RFEF”) was taken as a surrogate for myocardial reserve. The cut-off defined was 0.12; patients with RFEF ≤ 0.12 were categorized as the “bad” and those with RFEF > 0.12 as the “good” subset. The patients were further subdivided on the basis of their mitral regurgitation (MR) jet direction (central/eccentric). The percentage improvement in left ventricular end-systolic volume index (LVESVI) and MR grade were recorded 6 monthly.

Results

Analysis of the continuous variable “RFEF” in conjunction with jet direction was performed. At 12 months, the patient in good subset with central direction of jet showed improvement in LVESVI % in both groups (p = 0.428), while the patients in bad subset with eccentric direction of jet showed significantly higher improvement in LVESVI %, group II as compared to group I (p = 0.004).

Conclusion

This study thus identifies “RFEF” as a surrogate for reverse remodeling capacity. In association with MR jet direction, predicts the subset of moderate CIMR patients most likely to have maximum LVESVI and MR grade reduction.
Literatur
1.
Zurück zum Zitat Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology in India. Ann Glob Health. 2016;82:307–15.CrossRefPubMed Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology in India. Ann Glob Health. 2016;82:307–15.CrossRefPubMed
2.
Zurück zum Zitat Puskas JD, Williams WH, Duke PG, et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:797–808.CrossRef Puskas JD, Williams WH, Duke PG, et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:797–808.CrossRef
3.
Zurück zum Zitat Spartera M, Galderisi M, Mele D, et al. Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation. EurHeart J Cardiovasc Imaging. 2016;17:471–80. Spartera M, Galderisi M, Mele D, et al. Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation. EurHeart J Cardiovasc Imaging. 2016;17:471–80.
4.
Zurück zum Zitat Magne J, Sénéchal M, Dumesnil JG, Pibarot P. Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology. 2009;112:244–59.CrossRefPubMed Magne J, Sénéchal M, Dumesnil JG, Pibarot P. Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology. 2009;112:244–59.CrossRefPubMed
5.
Zurück zum Zitat Carpentier A. Cardiac valve surgery-the “French correction”. J Thorac Cardiovasc Surg. 1983;86:323–37. Carpentier A. Cardiac valve surgery-the “French correction”. J Thorac Cardiovasc Surg. 1983;86:323–37.
6.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:2440–92. Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:2440–92.
7.
Zurück zum Zitat Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation implications for management. Circulation. 2008;118:2298–303.CrossRefPubMed Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation implications for management. Circulation. 2008;118:2298–303.CrossRefPubMed
8.
Zurück zum Zitat Lamy A, Devereaux PJ, Prabhakaran D, et al. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med. 2013;368:1179–88.CrossRefPubMed Lamy A, Devereaux PJ, Prabhakaran D, et al. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med. 2013;368:1179–88.CrossRefPubMed
9.
Zurück zum Zitat Malhotra A, Sharma P, Garg P, Bishnoi A, Kothari J, Pujara J. Ring annuloplasty for ischemic mitral regurgitation a single center experience. Asian Cardiovasc Thorac Ann. 2014;22:781-6.CrossRefPubMed Malhotra A, Sharma P, Garg P, Bishnoi A, Kothari J, Pujara J. Ring annuloplasty for ischemic mitral regurgitation a single center experience. Asian Cardiovasc Thorac Ann. 2014;22:781-6.CrossRefPubMed
10.
Zurück zum Zitat Malhotra A, Ananthanarayanan C, Wadhawa V, et al. OPCABG for moderate CIMR in elderly patients: a superior option? Braz J Cardiovasc Surg. 2018;33:15–22.CrossRefPubMedPubMedCentral Malhotra A, Ananthanarayanan C, Wadhawa V, et al. OPCABG for moderate CIMR in elderly patients: a superior option? Braz J Cardiovasc Surg. 2018;33:15–22.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Yokoyama T, Baumgartner FJ, Gheissari A, Capouya ER, Panagiotides GP, Declusin RJ. Off-pump versus on-pump coronary bypass in high-risk subgroups. Ann Thorac Surg. 2000;70:1546–50.CrossRefPubMed Yokoyama T, Baumgartner FJ, Gheissari A, Capouya ER, Panagiotides GP, Declusin RJ. Off-pump versus on-pump coronary bypass in high-risk subgroups. Ann Thorac Surg. 2000;70:1546–50.CrossRefPubMed
12.
Zurück zum Zitat Levine HJ, Gaasch AWH. Ratio of regurgitant volume to end-diastolic volume: a major determinant of ventricular response to surgical correction of chronic volume overload. Am J Cardiol. 1983;52:406–10.CrossRefPubMed Levine HJ, Gaasch AWH. Ratio of regurgitant volume to end-diastolic volume: a major determinant of ventricular response to surgical correction of chronic volume overload. Am J Cardiol. 1983;52:406–10.CrossRefPubMed
13.
Zurück zum Zitat Fioretti P, Roelandt J, Tirtaman C, Bos E, Serruys PW. Value of the regurgitant volume to end diastolic volume ratio to predict the regression of left ventricular dimensions after valve replacement in aortic insufficiency. Eur Heart J. 1987;8:15–20.CrossRefPubMed Fioretti P, Roelandt J, Tirtaman C, Bos E, Serruys PW. Value of the regurgitant volume to end diastolic volume ratio to predict the regression of left ventricular dimensions after valve replacement in aortic insufficiency. Eur Heart J. 1987;8:15–20.CrossRefPubMed
14.
Zurück zum Zitat Ueno T, Sakata R, Iguro Y, et al. Left ventricular reconstruction with or without mitral annuloplasty. Ann Thorac Cardiovasc Surg. 2009;15:165–70.PubMed Ueno T, Sakata R, Iguro Y, et al. Left ventricular reconstruction with or without mitral annuloplasty. Ann Thorac Cardiovasc Surg. 2009;15:165–70.PubMed
15.
16.
Zurück zum Zitat Trento A, Goland S, De Robertis MA,. Czer LSC. COUNTERPOINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation. J Thorac Cardiovasc Surg. 2009;138:286–8.CrossRefPubMed Trento A, Goland S, De Robertis MA,. Czer LSC. COUNTERPOINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation. J Thorac Cardiovasc Surg. 2009;138:286–8.CrossRefPubMed
17.
Zurück zum Zitat Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation. 2001;104:I68–75.CrossRefPubMed Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation. 2001;104:I68–75.CrossRefPubMed
18.
Zurück zum Zitat Ryden T, Bech-Hanssen O, Brandrup-Wognesen G, Nilsson F, Svensson S, Jeppsson A. The importance of grade 2 ischemic mitral regurgitation in coronary artery bypass grafting. Eur J Cardiothorac Surg. 2001;20:276–81. Ryden T, Bech-Hanssen O, Brandrup-Wognesen G, Nilsson F, Svensson S, Jeppsson A. The importance of grade 2 ischemic mitral regurgitation in coronary artery bypass grafting. Eur J Cardiothorac Surg. 2001;20:276–81.
19.
Zurück zum Zitat Lindeboom JE, Jaarsma W, Kelder JC, Morshuis WJ, Visser CA. Mitral valve repair is not always needed in patients with functional mitral regurgitation undergoing coronary artery bypass grafting and/or aortic valve replacement. Neth Heart J. 2005;13:175–80. Lindeboom JE, Jaarsma W, Kelder JC, Morshuis WJ, Visser CA. Mitral valve repair is not always needed in patients with functional mitral regurgitation undergoing coronary artery bypass grafting and/or aortic valve replacement. Neth Heart J. 2005;13:175–80.
20.
Zurück zum Zitat Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 2004; 110: II-103–II-108. Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 2004; 110: II-103–II-108.
21.
Zurück zum Zitat Lam BK, Gillinov AM, Blackstone EH, et al. Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg. 2005;79:462–70.CrossRefPubMed Lam BK, Gillinov AM, Blackstone EH, et al. Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg. 2005;79:462–70.CrossRefPubMed
22.
Zurück zum Zitat Grossi EA, Crooke GA, DiGiorgi PL, et al. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Circulation. 2006;114:I-573–6.CrossRef Grossi EA, Crooke GA, DiGiorgi PL, et al. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Circulation. 2006;114:I-573–6.CrossRef
23.
24.
Zurück zum Zitat Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374:1932–41. Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374:1932–41.
25.
Zurück zum Zitat Chan KM, Punjabi PP, Flather M, et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012;126:2502–10. Chan KM, Punjabi PP, Flather M, et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012;126:2502–10.
26.
Zurück zum Zitat Fattouch K, Guccione F, Sampognaro R, et al. POINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009;138:278–85.CrossRefPubMed Fattouch K, Guccione F, Sampognaro R, et al. POINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009;138:278–85.CrossRefPubMed
27.
Zurück zum Zitat Dion R. Ischemic mitral regurgitation: when and how should it be corrected? J Heart Valve Dis. 1993;5:536–43. Dion R. Ischemic mitral regurgitation: when and how should it be corrected? J Heart Valve Dis. 1993;5:536–43.
28.
Zurück zum Zitat Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation long-term outcome and prognostic implications with quantitative doppler assessment. Circulation. 2001;103:1759–64.CrossRefPubMed Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation long-term outcome and prognostic implications with quantitative doppler assessment. Circulation. 2001;103:1759–64.CrossRefPubMed
29.
Zurück zum Zitat Penicka M, Linkova H, Lang O, et al. Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery. Circulation. 2009;120:1474–81.CrossRefPubMed Penicka M, Linkova H, Lang O, et al. Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery. Circulation. 2009;120:1474–81.CrossRefPubMed
30.
Zurück zum Zitat Yu HY, Su MY, Liao TY, Peng HH, Lin FY, Tseng WY. Functional mitral regurgitation in chronic ischemic coronary artery disease: analysis of geometric alterations of mitral apparatus with magnetic resonance imaging. J Thorac Cardiovasc Surg. 2004;128:543–51. Yu HY, Su MY, Liao TY, Peng HH, Lin FY, Tseng WY. Functional mitral regurgitation in chronic ischemic coronary artery disease: analysis of geometric alterations of mitral apparatus with magnetic resonance imaging. J Thorac Cardiovasc Surg. 2004;128:543–51.
31.
Zurück zum Zitat Beeri R, Yosefy C, Guerrero JL, et al. Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling a functional and molecular study. Circulation 2007; 116]:I-288–I-293. Beeri R, Yosefy C, Guerrero JL, et al. Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling a functional and molecular study. Circulation 2007; 116]:I-288–I-293.
32.
Zurück zum Zitat Gelsomino S, Lorusso R, Caciolli S, et al. Insights on left ventricular and valvular mechanisms of recurrent ischemic mitral regurgitation after restrictive annuloplasty and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2008;136:507–18.CrossRefPubMed Gelsomino S, Lorusso R, Caciolli S, et al. Insights on left ventricular and valvular mechanisms of recurrent ischemic mitral regurgitation after restrictive annuloplasty and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2008;136:507–18.CrossRefPubMed
33.
Zurück zum Zitat Gelsomino S, Lorusso R, Capecchi I, et al. Left ventricular reverse remodeling after undersized mitral ring annuloplasty in patients with ischemic regurgitation. Ann Thorac Surg. 2008;85:1319–30.CrossRefPubMed Gelsomino S, Lorusso R, Capecchi I, et al. Left ventricular reverse remodeling after undersized mitral ring annuloplasty in patients with ischemic regurgitation. Ann Thorac Surg. 2008;85:1319–30.CrossRefPubMed
34.
Zurück zum Zitat Kumanohoso T, Otsuji Y, Yoshifuku S, et al. Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction. J Thorac Cardiovasc Surg. 2003;125:135–43.CrossRefPubMed Kumanohoso T, Otsuji Y, Yoshifuku S, et al. Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction. J Thorac Cardiovasc Surg. 2003;125:135–43.CrossRefPubMed
35.
Zurück zum Zitat Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Jamil Tajik A. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:1400–6.CrossRefPubMed Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Jamil Tajik A. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:1400–6.CrossRefPubMed
36.
Zurück zum Zitat Magne J, Pibarot P, Dagenais F, Hachicha Z, Dumesnil JG, Sénéchal M. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation. 2007;115:782–91.CrossRefPubMed Magne J, Pibarot P, Dagenais F, Hachicha Z, Dumesnil JG, Sénéchal M. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation. 2007;115:782–91.CrossRefPubMed
Metadaten
Titel
“RFEF” and mitral regurgitation jet direction: surrogate markers for likelihood of left ventricle reverse remodeling in patients with moderate chronic ischemic mitral regurgitation
verfasst von
Sumbul Siddiqui
Amber Malhotra
Komal Shah
Pankaj Garg
Pranav Sharma
Vivek Wadhawa
Kartik Patel
Anand Shukla
Publikationsdatum
18.10.2018
Verlag
Springer Singapore
Erschienen in
Indian Journal of Thoracic and Cardiovascular Surgery / Ausgabe 2/2019
Print ISSN: 0970-9134
Elektronische ISSN: 0973-7723
DOI
https://doi.org/10.1007/s12055-018-0717-0

Weitere Artikel der Ausgabe 2/2019

Indian Journal of Thoracic and Cardiovascular Surgery 2/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.